Use this site to access recordings and presentations from National Conferences
Autism Society records most keynote and concurrent sessions at their annual conferences. You can see and hear those recordings by purchasing full online access, or individual recordings.
5965
Autism and the DSM-5
Saturday, July 28, 2012: 8:30 AM-10:00 AM
Golden Ballroom (Town and Country Resort and Convention Center)
From the earliest descriptions of autism, the field has wrestled with questions of what defines the disorder, how inclusive a net to cast, and how bright to define the boundaries around it. Questions also abound as to whether the autism spectrum is made up of discreet entities or is continuous, and whether one autism or many autisms exist. Asperger’s Disorder and Pervasive Developmental Disorder NOS have grown dramatically in prevalence, but experts still cannot reliably discriminate between them. This presentation will review the history of the diagnosis of autism, and the rationale for changes being proposed for DSM 5.
Presenter:
Bryan King, M.D.
Professor & Vice Chair of Psychiatry & Behavioral Sciences; Director, Seattle Children's Autism Center/Child & Adolescent Psych.
University of Washington and Seattle Children's Hospital
Bryan King has been focused on psychiatric aspects of neurodevelopmental disorders, and upon the pathogenesis and treatment of severe behavioral disturbance in autism in particular. He has participated in several clinical trials of therapeutics in autism at all stages of development, and has been continuously funded by the National Institutes of Health to do this and related work as a Principal Investigator since 1990. He chaired the multi-site clinical trial funded by the NIH, STAART (studies to advance autism research and treatment) Centers, examining the potential role for citalopram in the treatment of children with autism who have significant problems with repetitive behaviors. His experience with clinical trials and the extraordinary clinical program at Seattle Children’s Hospital makes his team highly sought after collaborators for multi-site clinical trials in autism and they are partners in several important networks. Dr. King has received two lifetime achievement awards, from the American Psychiatric Association and American Academy of Child and Adolescent Psychiatry, for his work. He currently serves as the Co-Chair of the Autism and Intellectual Disability Committee of the American Academy of Child and Adolescent Psychiatry, and is a member of the DSM-5 workgroup responsible for writing the current definition of autism spectrum disorder.